Diosma Life Sciences

Manufacturing and exporting of pharmaceutical and nutraceutical products by Diosma Life Sciences in India.

About Diosma Life Sciences

Diosma Life Sciences is a Healthcare company. Manufacturing and exporting of pharmaceutical and nutraceutical products by Diosma Life Sciences in India. The company has 1 employees. Its Indian entity Diosma Lifesciences Private Limited reported revenue of β‚Ή4.55 Cr. Diosma Life Sciences offers products and services including Tablets and Capsules and Injectables. Its focus areas include Nutraceuticals, Export, International Distribution and Pharmaceuticals.

Company details

Diosma Life Sciences Is Recognized As A Manufacturer And Exporter Of High-quality Who-gmp Compliant Finished Dosage Forms, With Operations Based In Mumbai Since 2014. A Wide Spectrum Of Products, Including Tablets, Capsules, Syrups, Injectables, And Ointments, Is Produced In Facilities Located In Pollution-free Industrial Areas Of Uttarakhand. Commitment To Safety, Efficacy, And International Standards Is Demonstrated Through A Robust Quality Management System That Emphasizes Continuous Improvement And Ethical Practices. The Company Serves Domestic And Global Markets With A Focus On Pharmaceutical, Nutraceutical, And Ayurvedic Formulations, Ensuring Products Meet Global Requirements.

Key Metrics
  • Indian entity revenue
    ₹4.55 Cr

    FY 2025 · -2% YoY

  • Indian entity net loss
    -₹63,187

    FY 2025 · 0% margin

  • Indian entity EBITDA
    ₹14.7 Lakh

    FY 2025 · 3% margin

  • Employee Count
    1

Products & Services of Diosma Life Sciences

Diosma Life Sciences offers a comprehensive portfolio of products and services, including Tablets and Capsules and Injectables.

Tablets and Capsules
Pharmaceutical Products

Tablets and capsules are produced as finished dosage forms that comply with WHO-GMP standards for various therapeutic applications.

Injectables
Pharmaceutical Products

Injectables are manufactured using advanced technology to ensure safety and efficacy in medical treatments.

Board of directors of Diosma Lifesciences Private Limited (Diosma Life Sciences)

Diosma Lifesciences Private Limited is the primary company behind Diosma Life Sciences. The board of Diosma Lifesciences Private Limited currently have 2 directors; the longest-serving is Girish Chandrapati Singh, appointed in 2014. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Girish Chandrapati Singh
DIN 06843776
Director04 Jun 201412 yrs 5 moDiosma Lifesciences Private Limited
Priyanka Girish Singh
DIN 07590662
Director16 Aug 201610 yrs 3 moDiosma Lifesciences Private Limited

Financials of Diosma Life Sciences

Figures of Diosma Lifesciences Private Limited, the primary company behind Diosma Life Sciences, for FY 2025. Revenue was ₹4.55 Cr (-2% year on year). Net loss was -₹63,187 (0% margin). EBITDA was ₹14.7 Lakh (3% margin). Revenue has grown at a compounded annual rate of +8% over three years and +17% over five years.

  • ₹4.55 CrRevenue · FY 2025 · -2% YoY
  • -₹63,187Net loss · 0% margin
  • ₹14.7 LakhEBITDA · 3% margin
  • ₹1 LakhPaid-up capital
  • 14Employees (provident fund records)
  • +8%Revenue CAGR, 3 years
  • +17%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Diosma Lifesciences Private Limited are on its company page.

Premium access

Detailed financial statements for Diosma Life Sciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Diosma Life Sciences

Diosma Life Sciences has 1 employees.

The primary company behind Diosma Life Sciences, Diosma Lifesciences Private Limited, reported revenue of β‚Ή4.55 Cr for FY 2025, down 2% year on year.

Diosma Life Sciences Is Recognized As A Manufacturer And Exporter Of High-quality Who-gmp Compliant Finished Dosage Forms, With Operations Based In Mumbai Since 2014. A Wide Spectrum Of Products, Including Tablets, Capsules, Syrups, Injectables, And Ointments, Is Produced In Facilities Located In Pollution-free Industrial Areas Of Uttarakhand. Commitment To Safety, Efficacy, And International Standards Is Demonstrated Through A Robust Quality Management System That Emphasizes Continuous Improvement And Ethical Practices. The Company Serves Domestic And Global Markets With A Focus On Pharmaceutical, Nutraceutical, And Ayurvedic Formulations, Ensuring Products Meet Global Requirements.

Diosma Life Sciences offers Tablets and Capsules and Injectables.

Diosma Life Sciences operates through Diosma Lifesciences Private Limited.

The legal entities of Diosma Life Sciences currently have 2 directors, including Girish Chandrapati Singh, Priyanka Girish Singh.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available